Oncotarget
C57BL6 mice bearing orthotopic brain tumors were treated with a therapeutic agents 12 days after tumor implantation. In this particular animal, two tumor nodules developed along the injection track and both showed tumor accumulation of 125I-labeled SSLs when TNF-α was co-administered. See Qiao et al.
A conspiracy of glioma and endothelial cells to invade the normal brain. |
https://doi.org/10.18632/oncotarget.219 Abdessamad Zerrouqi, and Erwin G Van Meir |
1-4 |
PDF | HTML | How to cite | Order a Reprint |
Targeting Transcription Through Inhibition of TBP |
https://doi.org/10.18632/oncotarget.226 Thaddeus T. Schug |
5-7 |
PDF | HTML | How to cite | Order a Reprint |
The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target |
https://doi.org/10.18632/oncotarget.211 Gabriel J. Villares, Maya Zigler, and Menashe Bar-Eli |
8-17 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Identification of Kinase Inhibitors that Target Transcription Initiation by RNA Polymerase II |
https://doi.org/10.18632/oncotarget.212 José M. Morachis, Ruo Huang, and Beverly M. Emerson |
18-28 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.213 Nijiro Nohata, Yaeko Sone, Toyoyuki Hanazawa, Miki Fuse, Naoko Kikkawa, Hirofumi Yoshino, Takeshi Chiyomaru, Kazumori Kawakami, Hideki Enokida, Masayuki Nakagawa, Makio Shozu, Yoshitaka Okamoto, and Naohiko Seki |
29-42 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Hsp90 can Accommodate the Simultaneous Binding of the FKBP52 and HOP Proteins |
https://doi.org/10.18632/oncotarget.225 Zacariah L. Hildenbrand, Sudheer K. Molugu, Nadia Herrera, Citlally Ramirez, Chuan Xiao, and Ricardo A. Bernal |
43-58 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
A Robust Approach to Enhance Tumor-selective Accumulation of Nanoparticles |
https://doi.org/10.18632/oncotarget.227 Yuan Qiao, Xin Huang, Sridhar Nimmagadda, Renyuan Bai, Verena Staedtke, Catherine A. Foss, Ian Cheong, Matthias Holdhoff, Yoshinori Kato, Martin G. Pomper, Gregory J. Riggins, Kenneth W. Kinzler, Luis A. Diaz, Bert Vogelstein, and Shibin Zhou |
59-68 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
FAM190A Rearrangements Provide a Multitude of Individualized Tumor Signatures and Neo-antigens in Cancer |
https://doi.org/10.18632/oncotarget.220 Francesca Scrimieri, Eric S. Calhoun, Kalpesh Patel, Rigu Gupta, David L. Huso, Ralph H. Hruban, and Scott E. Kern |
69-75 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Targeting Translation Dependence in Cancer |
https://doi.org/10.18632/oncotarget.218 Abba Malina, Regina Cencic, and Jerry Pelletier |
76-88 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence |
https://doi.org/10.18632/oncotarget.221 Suzan K. Chao, Susan Band Horwitz, and Hayley M. McDaid |
89-98 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Eradicating cancer cells: struggle with a chameleon |
https://doi.org/10.18632/oncotarget.222 Jiabo Di, Tjitske Duiveman-de Boer, Carl G. Figdor, and Ruurd Torensma |
99-101 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC